A Case of Refractory SAPHO Syndrome Treated with Etanercept
Journal of Rheumatic Diseases
;
: 51-54, 2012.
Article
in Korean
| WPRIM
| ID: wpr-45768
ABSTRACT
SAPHO syndrome, which has different skin changes and osteoarticular inflammation, is an acronym that stands for synovitis, acne, pustulosis, hyperostosis, and osteitis. Treatment of SAPHO syndrome includes non-steroidal anti-inflammatory drugs (NSAIDs), anti-rheumatic drugs, such as colchicines, corticosteroids and bisphosphonates, and disease-modifying agents. However, the treatment of SAPHO syndrome is controversial because it is a new clinical entity with unclear etiopathogenesis and inadequate clinical studies. We report a case with refractory SAPHO syndrome, which was successfully treated with a tumor necrosis factor (TNF)-alpha blocker.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Osteitis
/
Skin
/
Synovitis
/
Immunoglobulin G
/
Hyperostosis
/
Tumor Necrosis Factor-alpha
/
Adrenal Cortex Hormones
/
Acne Vulgaris
/
Receptors, Tumor Necrosis Factor
/
Antirheumatic Agents
Language:
Korean
Journal:
Journal of Rheumatic Diseases
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS